Cited by 45Biochemical Acid Research StudiesMitochondrial Function and PathologyNeurological Disorders and Treatments

Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death

Open access
Weidinger, Adelheid, Milivojev, Nadja, Hosmann, Arthur, Duvigneau, J. Catharina, Szabo, Csaba, Törö, Gabor, Rauter, Laurin, Vaglio-Garro, Annette +12 more·2023·Redox Biology

Abstract

Brain injury is accompanied by neuroinflammation, accumulation of extracellular glutamate and mitochondrial dysfunction, all of which cause neuronal death. The aim of this study was to investigate the impact of these mechanisms on neuronal death. Patients from the neurosurgical intensive care unit suffering aneurysmal subarachnoid hemorrhage (SAH) were recruited retrospectively from a respective database. In vitro experiments were performed in rat cortex homogenate, primary dissociated neuronal cultures, B35 and NG108-15 cell lines. We employed methods including high resolution respirometry, electron spin resonance, fluorescent microscopy, kinetic determination of enzymatic activities and immunocytochemistry. We found that elevated levels of extracellular glutamate and nitric oxide (NO) metabolites correlated with poor clinical outcome in patients with SAH. In experiments using neuronal cultures we showed that the 2-oxoglutarate dehydrogenase complex (OGDHC), a key enzyme of the glutamate-dependent segment of the tricarboxylic acid (TCA) cycle, is more susceptible to the inhibition by NO than mitochondrial respiration. Inhibition of OGDHC by NO or by succinyl phosphonate (SP), a highly specific OGDHC inhibitor, caused accumulation of extracellular glutamate and neuronal death. Extracellular nitrite did not substantially contribute to this NO action. Reactivation of OGDHC by its cofactor thiamine (TH) reduced extracellular glutamate levels, Ca2+ influx into neurons and cell death rate. Salutary effect of TH against glutamate toxicity was confirmed in three different cell lines. Our data suggest that the loss of control over extracellular glutamate, as described here, rather than commonly assumed impaired energy metabolism, is the critical pathological manifestation of insufficient OGDHC activity, leading to neuronal death.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.redox.2023.102669

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endogenous NO serves as a posttranslational regulator of OGDHC and may affect toxic effects of glutamate.

    “Previous studies have shown that elevated levels of glutamate may upregulate the activity of OGDHC and that endogenous NO serves as a posttranslational regulator of OGDHC and may affect toxic effects of glutamate (Weidinger et al., 2023).”

    From Toxic Concentrations of Glutamate Induce Ferroptosis without Affecting Mitochondrial Respiration in Rodent Brain Slice Cultures (2026) · cites this paper as Weidinger et al., 2023

    The Results (page unavailable) report that glutamate treatment increased OGDHC activity and that NO inhibited it and increased glutamate-induced cell damage. The Discussion (page unavailable) links increased NO production to reduced OGDHC activity and toxic extracellular glutamate. Our copy does not establish that NO acts through a posttranslational modification of OGDHC, so that specific characterization is unsupported. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In primary neuronal cultures, glutamate toxicity primarily targets neurons, causing a marked reduction in tyrosine hydroxylase-positive neurons and neurite degeneration.

    “In primary neuronal cultures, it has been shown that glutamate toxicity primarily targets neurons, as evidenced by a marked reduction in the number of tyrosine hydroxylase-positive neurons together with neurite degeneration (Weidinger et al., 2023).”

    From Toxic Concentrations of Glutamate Induce Ferroptosis without Affecting Mitochondrial Respiration in Rodent Brain Slice Cultures (2026) · cites this paper as Weidinger et al., 2023

    The Results (Fig. 6; page not provided) report that glutamate reduced the number of tyrosine hydroxylase-positive neurons and shortened their neurites in primary murine mesencephalic cultures. The paper does not establish that glutamate primarily targets neurons rather than other cell types; that comparative part of the claim is unsupported. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Elevated levels of glutamate may upregulate the activity of OGDHC.

    “Previous studies have shown that elevated levels of glutamate may upregulate the activity of OGDHC and that endogenous NO serves as a posttranslational regulator of OGDHC and may affect toxic effects of glutamate (Weidinger et al., 2023).”
  • Restoration of OGDHC activity attenuated glutamate-induced Ca2+ accumulation and neuronal cell death.

    “In a previous study, restoration of the mitochondrial enzyme complex oxoglutarate dehydrogenase complex (OGDHC) activity attenuated glutamate-induced Ca2+ accumulation and neuronal cell death (Weidinger et al., 2023), supporting a mechanistic link between glutamate metabolism, excitotoxic Ca2+ signaling, and neuronal survival.”
  • Memantine, an NMDA receptor antagonist, protected neuronal primary cells from glutamate-induced death.

    “It has been shown that memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, protected neuronal primary cells from glutamate-induced death (Weidinger et al., 2023).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. [2]Akhtar M.W. Sanz-Blasco S. Dolatabadi N. Parker J. Chon K. Lee M.S. Soussou W. McKercher S.R. Ambasudhan R. Nakamura T. Lipton S.A. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation Nat. Commun. 7 2016 10.1038/ncomms10242 PMC4729876 26743041 · DOI
  2. [4]Sanchez-Padilla J. Guzman J.N. Ilijic E. Kondapalli J. Galtieri D.J. Yang B. Schieber S. Oertel W. Wokosin D. Schumacker P.T. Surmeier D.J. Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase Nat. Neurosci. 17 2014 832 840 10.1038/nn.3717 24816140 PMC4131291 · DOI
  3. [5]Kozlov A.v. Lancaster J.R. Meszaros A.T. Weidinger A. Mitochondria-meditated pathways of organ failure upon inflammation Redox Biol. 13 2017 170 181 10.1016/j.redox.2017.05.017 28578275 PMC5458092 · DOI
  4. [6]Richardson A.R. Payne E.C. Younger N. Karlinsey J.E. Thomas V.C. Becker L.A. Navarre W.W. Castor M.E. Libby S.J. Fang F.C. Multiple targets of nitric oxide in the tricarboxylic acid cycle of salmonella enterica serovar typhimurium Cell Host Microbe 10 2011 33 43 10.1016/j.chom.2011.06.004 21767810 PMC3142370 · DOI
  5. [8]Hantraye P. Brouillet E. Ferrante R. Palfi S. Dolan R. Matthews R.T. Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 2 1996 1017 1021 10.1038/nm0996-1017 8782460 · DOI
  6. [9]Üçal M. Kraitsy K. Weidinger A. Paier-Pourani J. Patz S. Fink B. Molcanyi M. Schäfer U. Comprehensive profiling of modulation of nitric oxide levels and mitochondrial activity in the injured brain: an experimental study based on the fluid percussion injury model in rats J. Neurotrauma 34 2017 475 486 10.1089/neu.2016.4411 27165518 · DOI
  7. [10]Hosmann A. Milivojev N. Dumitrescu S. Reinprecht A. Weidinger A. Kozlov A.v. Cerebral nitric oxide and mitochondrial function in patients suffering aneurysmal subarachnoid hemorrhage—a translational approach Acta Neurochir. 163 2021 139 149 10.1007/s00701-020-04536-x 32839865 PMC7778629 · DOI
  8. [11]van Faassen E.E. Bahrami S. Feelisch M. Hogg N. Kelm M. Kim-Shapiro D.B. v Kozlov A. Li H. Lundberg J.O. Mason R. Nohl H. Rassaf T. Samouilov A. Slama-Schwok A. Shiva S. Vanin A.F. Weitzberg E. Zweier J. Gladwin M.T. Nitrite as regulator of hypoxic signaling in mammalian physiology Med. Res. Rev. 29 2009 683 741 10.1002/med.20151 19219851 PMC2725214 · DOI · Paper page
  9. [12]Nicholls D.G. The glutamatergic nerve terminal Eur. J. Biochem. 212 1993 613 631 10.1111/j.1432-1033.1993.tb17700.x 8096460 · DOI
  10. [13]Woitzik J. Pinczolits A. Hecht N. Sandow N. Scheel M. Drenckhahn C. Dreier J.P. Vajkoczy P. Excitotoxicity and metabolic changes in association with infarct progression Stroke 45 2014 1183 1185 10.1161/STROKEAHA.113.004475 24643407 · DOI
  11. [14]Bading H. Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations J. Exp. Med. 214 2017 569 578 10.1084/jem.20161673 28209726 PMC5339681 · DOI
  12. [16]Rimmele T.S. Li S. Andersen J.V. Westi E.W. Rotenberg A. Wang J. Aldana B.I. Selkoe D.J. Aoki C.J. Dulla C.G. Rosenberg P.A. Neuronal loss of the glutamate transporter GLT-1 promotes excitotoxic injury in the Hippocampus Front. Cell. Neurosci. 15 2021 10.3389/fncel.2021.788262 PMC8752461 35035352 · DOI
  13. [17]Mcnair L.F. v Andersen J. Aldana B.I. Hohnholt M.C. Nissen J.D. Sun Y. Fischer K.D. Sonnewald U. Nyberg N. Webster S.C. Kapur K. Rimmele T.S. Barone I. Hawks-Mayer H. Lipton J.O. Hodgson N.W. Hensch T.K. Chiye X. Aoki J. Rosenberg P.A. Helle X. Waagepetersen S. Deletion of Neuronal GLT-1 in Mice Reveals its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function 2019 10.1523/JNEUROSCI.0894-18.2019 PMC6670249 30926746 · DOI
  14. [19]Yao L. Grand T. Hanson J. Paoletti P. Zhou Q. Higher ambient synaptic glutamate at inhibitory versus excitatory neurons differentially impacts NMDA receptor activity Nat. Commun. 9 2018 10.1038/s41467-018-06512-7 PMC6167324 30275542 · DOI
  15. [20]Romanos J. Benke D. Saab A.S. Zeilhofer H.U. Santello M. Differences in glutamate uptake between cortical regions impact neuronal NMDA receptor activation Commun Biol 2 2019 1 15 10.1038/s42003-019-0367-9 30963115 PMC6451009 · DOI
  16. [21]ben Fredj N. Burrone J. A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse Nat. Neurosci. 12 2009 751 758 10.1038/nn.2317 19430474 PMC2738656 · DOI
  17. [22]She X. Lan B. Tian H. Tang B. Cross talk between ferroptosis and cerebral ischemia Front. Neurosci. 14 2020 10.3389/fnins.2020.00776 PMC7423876 32848555 · DOI
  18. [23]Bunik V.I. Kabysheva M.S. Klimuk E.I. Storozhevykh T.P. Pinelis V.G. Phosphono analogues of 2-oxoglutarate protect cerebellar granule neurons upon glutamate excitotoxicity Ann N Y Acad Sci 2009 Blackwell Publishing Inc. 521 529 10.1111/j.1749-6632.2009.04709.x 19723099 · DOI
  19. [24]Kabysheva M.S. Storozhevykh T.P. Pinelis V.G. Bunik V.I. Synthetic regulators of the 2-oxoglutarate oxidative decarboxylation alleviate the glutamate excitotoxicity in cerebellar granule neurons Biochem. Pharmacol. 77 2009 1531 1540 10.1016/j.bcp.2009.02.001 19426691 · DOI
  20. [25]Bunik V.I. v Artiukhov A. v Kazantsev A. Aleshin V.A. Boyko A.I. Ksenofontov A.L. v Lukashev N. v Graf A. Administration of phosphonate inhibitors of dehydrogenases of 2-oxoglutarate and 2-oxoadipate to rats elicits target-specific metabolic and physiological responses Front. Chem. 10 2022 892284 10.3389/fchem.2022.892284 PMC9252169 35795216 · DOI
  21. [26]v Artiukhov A. v Kazantsev A. v Lukashev N. Bellinzoni M. Bunik V.I. Selective inhibition of 2-oxoglutarate and 2-oxoadipate dehydrogenases by the phosphonate analogs of their 2-oxo acid substrates Front. Chem. 8 2020 596187 10.3389/fchem.2020.596187 PMC7835950 33511099 · DOI
  22. [27]Artiukhov A.v. Grabarska A. Gumbarewicz E. Aleshin V.A. Kähne T. Obata T. Kazantsev A.v. Lukashev N.v. Stepulak A. Fernie A.R. Bunik V.I. Synthetic analogues of 2-oxo acids discriminate metabolic contribution of the 2-oxoglutarate and 2-oxoadipate dehydrogenases in mammalian cells and tissues Sci. Rep. 10 2020 10.1038/s41598-020-58701-4 PMC7002488 32024885 · DOI
  23. [28]Boyko A. Ksenofontov A. Ryabov S. Baratova L. Graf A. Bunik V. Delayed influence of spinal cord injury on the amino acids of NO• metabolism in rat cerebral cortex is attenuated by thiamine Front. Med. 4 2017 10.3389/fmed.2017.00249 PMC5775235 29379782 · DOI
  24. [29]Boyko A. Tsepkova P. Aleshin V. Artiukhov A. Mkrtchyan G. Ksenofontov A. Baratova L. Ryabov S. Graf A. Bunik V. Severe spinal cord injury in rats induces chronic changes in the spinal cord and cerebral cortex metabolism, adjusted by thiamine that improves locomotor performance Front. Mol. Neurosci. 14 2021 10.3389/fnmol.2021.620593 PMC8044794 33867932 · DOI
  25. [30]Mkrtchyan G.v. Üçal M. Müllebner A. Dumitrescu S. Kames M. Moldzio R. Molcanyi M. Schaefer S. Weidinger A. Schaefer U. Hescheler J. Duvigneau J.C. Redl H. Bunik V.I. Kozlov A.v. Thiamine preserves mitochondrial function in a rat model of traumatic brain injury, preventing inactivation of the 2-oxoglutarate dehydrogenase complex Biochim. Biophys. Acta Bioenerg. 1859 2018 925 931 10.1016/j.bbabio.2018.05.005 29777685 · DOI
  26. [31]Ohkuma S. Katsura M. Chen D.Z. Chen S.H. Kuriyama K. Presence of N-methyl-d-aspartate (NMDA) receptors in neuroblastoma × glioma hybrid NG108-15 cells-analysis using [45Ca2+]influx and [3H]MK-801 binding as functional measures Mol. Brain Res. 22 1994 166 172 10.1016/0169-328X(94)90044-2 7912400 · DOI
  27. [32]Nicholls D.G. Budd S.L. Mitochondria and neuronal survival Physiol. Rev. 80 2000 315 360 10.1152/physrev.2000.80.1.315 10617771 · DOI · Paper page
  28. [33]Khodorov B. Glutamate-induced deregulation of calcium homeostasis and mitochondrial dysfunction in mammalian central neurones Prog. Biophys. Mol. Biol. 86 2004 279 351 10.1016/j.pbiomolbio.2003.10.002 15288761 · DOI
  29. [34]Nicholls D.G. Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts Trends Neurosci. 23 2000 166 174 10.1016/S0166-2236(99)01534-9 10717676 · DOI · Paper page
  30. [35]Duchen M.R. Surin A. Jacobson J. Imaging mitochondrial function in intact cells Methods Enzymol. 361 2003 353 389 10.1016/S0076-6879(03)61019-0 12624920 · DOI
  31. [36]Gram M. Sveinsdottir S. Cinthio M. Sveinsdottir K. Hansson S.R. Mörgelin M. Åkerström B. Ley D. Extracellular hemoglobin - mediator of inflammation and cell death in the choroid plexus following preterm intraventricular hemorrhage J. Neuroinflammation 11 2014 10.1186/s12974-014-0200-9 PMC4269927 25441622 · DOI
  32. [37]Kapralov A. Vlasova I.I. Feng W. Maeda A. Walson K. Tyurin V.A. Huang Z. Aneja R.K. Carcillo J. Bayir H. Kagan V.E. Peroxidase activity of hemoglobin·haptoglobin complexes. Covalent aggreation and oxidative stress in plasma and macrophages J. Biol. Chem. 284 2009 30395 30407 10.1074/jbc.M109.045567 19740759 PMC2781594 · DOI · Paper page
  33. [38]Mkrtchyan G. Graf A. Bettendorff L. Bunik V. Cellular thiamine status is coupled to function of mitochondrial 2-oxoglutarate dehydrogenase Neurochem. Int. 101 2016 66 75 10.1016/j.neuint.2016.10.009 27773789 · DOI
  34. [39]Monné M. Palmieri F. Antiporters of the mitochondrial carrier family Curr Top Membr 2014 Academic Press Inc. 289 320 10.1016/B978-0-12-800223-0.00008-6 24745987 · DOI
  35. [40]Anne C. Gasnier B. Vesicular neurotransmitter transporters: mechanistic aspects Curr Top Membr 2014 Academic Press Inc. 149 174 10.1016/B978-0-12-800223-0.00003-7 24745982 · DOI
  36. [41]Denker A. Rizzoli S.O. Synaptic vesicle pools: an update Front. Synaptic Neurosci. 2 2010 10.3389/fnsyn.2010.00135 PMC3059705 21423521 · DOI
  37. [42]Moulder K.L. Mennerick S. Reluctant vesicles contribute to the total readily releasable pool in glutamatergic hippocampal neurons J. Neurosci. 25 2005 3842 3850 10.1523/JNEUROSCI.5231-04.2005 15829636 PMC6724923 · DOI
  38. [43]Daniels R.W. Miller B.R. DiAntonio A. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration Neurobiol. Dis. 41 2011 415 420 10.1016/j.nbd.2010.10.009 20951206 PMC3014407 · DOI
  39. [45]Yang W.S. Stockwell B.R. Ferroptosis: death by lipid peroxidation Trends Cell Biol. 26 2016 165 176 10.1016/j.tcb.2015.10.014 26653790 PMC4764384 · DOI · Paper page
  40. [46]Thomson A.D. Guerrini I. Marshall E.J. The evolution and treatment of Korsakoff's syndrome out of sight, out of mind? Neuropsychol. Rev. 22 2012 81 92 10.1007/s11065-012-9196-z 22569770 PMC3545191 · DOI
  41. [47]Aleshin V.A. Mkrtchyan G.v. Kaehne T. Graf A.v. Maslova M.v. Bunik V.I. Diurnal regulation of the function of the rat brain glutamate dehydrogenase by acetylation and its dependence on thiamine administration J. Neurochem. 153 2020 80 102 10.1111/jnc.14951 31886885 · DOI
  42. [48]Dumitrescu S.D. Meszaros A.T. Puchner S. Weidinger A. Boros M. Redl H. Kozlov A.v. EPR analysis of extra- and intracellular nitric oxide in liver biopsies Magn. Reson. Med. 77 2017 2372 2380 10.1002/mrm.26291 27368066 · DOI

Cited by

Sorted by citations

Authors
Weidinger, A., Milivojev, N., Hosmann, A., Duvigneau, J. C., Szabo, C., Törö, G., Rauter, L., Vaglio-Garro, A., Mkrtchyan, G. V., Trofimova, L., Sharipov, R. R., Surin, A. M., Krasilnikova, I. A., Pinelis, V. G., Tretter, L., Moldzio, R., Bayır, H., Kagan, V. E., Bunik, V. I., & Kozlov, A. V.
Affiliations
  • Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA (AT)
  • Medical University of Vienna (AT)
  • University of Veterinary Medicine Vienna (AT)
  • Lomonosov Moscow State University (RU)
  • Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
  • Ministry of Health of the Russian Federation (RU)
  • University of Pittsburgh (US)
  • Sechenov University (RU)
Corresponding author
Kozlov, Andrey V.
Venue
Redox Biology
Publisher
Elsevier BV
Published
2023-06
Volume
62
Pages
102669
ISSN
2213-2317 (ISSN-L)
OpenAlex
W4323928491
Cited by
45
References
6
Citations by year
2026: 11 · 2025: 15 · 2024: 14 · 2023: 5
FWCI
4.42
Type
journal article
Language
en
Open access
Locations
  • Redox Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Austrian Science Fund (33799)
  • National Institutes of Health (NS076511)
  • Ministry of Education and Science of the Russian Federation (FGFU-2022-0012, 0520-2019-0029)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
2-oxoglutarate dehydrogenase, glutamate excitotoxicity, neuronal cell death, aneurysmal subarachnoid hemorrhage, nitric oxide, thiamine, mitochondrial respiration, TCA cycle, neuroinflammation, mitochondrial dysfunction, calcium influx, neurosurgical intensive care
MeSH terms
Animals, Cytoplasm, Ketoglutarate Dehydrogenase Complex, Mitochondria, Nitric Oxide, Retrospective Studies, Thiamine, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review